On the contrary, in SY5Y neuroblastoma cells overexpressing APP, mimicking Alzheimer’s disease, treatment with ADAM9 pro-domains inhibited the activity of ADAM9 but reduced the production of Aβ peptides. This evidence concerns the gene ADAM9 and Alzheimer disease.